Menu

Author Sues Journal

The American Diabetes Association faces a lawsuit after journal editors express concern over several papers.

Feb 10, 2015
Kerry Grens

WIKIMEDIA, BILL BRADFORDA professor from the State University of Campinas in São Paolo, Brazil, has asked the U.S. courts to put a stop to actions by the journal Diabetes, which has issued expressions of concern over several of his papers. According to the lawsuit, obtained by the Boston Business Journal, Diabetes is looking into a number of papers by Mário Saad and may retract them.

“Most detrimental,” the complaint states, “the ADA [American Diabetes Association, which publishes Diabetes] stated that it will not consider, for publication in any ADA journal any submissions authored by any of the faculty of (Saad’s) University until the issues described in the expression of concern have been appropriately reviewed and addressed by the University.” 

Retraction Watch pointed out that last year Saad and colleagues pulled a 2009 paper published in Arquivos Brasileiros de Endocrinologia & Metabologia for plagiarism.

The recent expressions of concern regarding four papers in Diabetes were issued because of the possibility of manipulated or fabricated data. Saad’s institution conducted an investigation, which found, Saad told Retraction Watch, “only editing mistakes that can be corrected by erratum.” The Boston Business Journal reported that the American Diabetes Association has asked the university to re-open the investigation.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.